GGrantIndex
Sort

17,828 grants matching crispr

Finding Protein Sequence Motifs--methods And Applications

$335,974
Eugene V Koonin · National Library Of Medicine · ZIA · FY2018 · LM

Role of XIRP2 in hair cell function and degeneration

$335,966
Jung-Bum Shin · University Of Virginia · R01 · FY2016 · DC

Role of XIRP2 in hair cell function and degeneration

$335,966
Jung-Bum Shin · University Of Virginia · R01 · FY2017 · DC

Uncovering the mechanism and role of a widespread anti-CRISPR-Cas9 protein

$335,738
Joseph Bondy-Denomy · University Of California, San Francisco · R01 · FY2018 · GM

Mechanisms and Functional Consequences of Selective miRNA transfer via extracellular vesicles

$335,676
James G. Patton · Vanderbilt University · P01 · FY2024 · CA

Investigate and inhibit microglia support of brain metastases

$335,644
Melanie Hayden Gephart · Stanford University · U54 · FY2024 · CA

Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology

$335,500
Robert D. Bowles · University Of Utah · R01 · FY2020 · AR

Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology

$335,500
Robert D. Bowles · University Of Utah · R01 · FY2023 · AR

Sequence-specific CRISPR mediated inflammatory cytokine receptor modulation for the treatment of inflammatory intervertebral disc pathology

$335,500
Robert D. Bowles · University Of Utah · R01 · FY2019 · AR

Identifying Functional Drivers of MYC Activation via Developmental Enhancers in Diffuse Large B-cell Lymphoma

$335,470
Russell James Hubbard Ryan · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

Germline transmission of epigenetic alterations to offspring

$335,466
Ramji Kumar Bhandari · University Of Missouri-Columbia · R01 · FY2025 · ES

Epigenetic and Genetic Vulnerabilities in Synovial Sarcoma

$335,415
Marc Ladanyi · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA

Cellular and Molecular Basis of Human Primordial Germ Cell Specification

$335,400
Amander Clark · University Of California Los Angeles · R01 · FY2020 · HD

The roles of midbody associated mRNAs in regulating cell proliferation and differentiation

$335,396
Rytis Prekeris · University Of Colorado Denver · R01 · FY2021 · GM

Project 3: Systematic characterization of factors controlling breast cancer progression and resistance

$335,096
Michael C Bassik · Stanford University · U54 · FY2024 · CA

Training Program in Stem Cell Translational Medicine for Neurological Disorders

$335,084
Leslie Michels Thompson · University Of California-Irvine · T32 · FY2023 · NS

Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer

$334,994
Dingcheng Gao · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA

Regulation of KSHV replication by N6-methyladenosine (m6A)

$334,965
Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA

Targeting parasite-host communication to combat liver fluke-induced bile duct cancer

$334,942
Paul J Brindley · George Washington University · R01 · FY2020 · CA

Evaluating the utility of cis-regulatory element graphs for modeling gene regulation

$334,685
Jill Elizabeth Moore · Univ Of Massachusetts Med Sch Worcester · R03 · FY2023 · OD

Targeting PTPN11 dependent Hematologic Malignancies

$334,662
Bill H Chang · Oregon Health & Science University · R01 · FY2024 · CA

Mechanisms of venetoclax combination activity in acute myeloid leukemia

$334,662
Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2024 · CA

Epidermal Gene Regulation by Transcription Elongation and Termination

$334,590
Xiaomin Bao · Northwestern University · R01 · FY2024 · AR

MegaTALS: hyperspecific reagents for targeted gene modification and correction

$334,400
Barry L. Stoddard · Fred Hutchinson Cancer Research Center · R01 · FY2014 · GM

MegaTALS: hyperspecific reagents for targeted gene modification and correction

$334,400
Barry L. Stoddard · Fred Hutchinson Cancer Research Center · R01 · FY2017 · GM